Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients
Clinical trial NCT04364035 · COMPLETED
Trial details
- NCT number
- NCT04364035
- Sponsor
- Aelix Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2022-10-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.